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The world is steadily retreating from depen-
dence on asbestos. In 2006 the International
Labour Organization (ILO 2006) and World
Health Organization (WHO 2006a) jointly
declared that the most efﬁcient way to elimi-
nate asbestos-related diseases is to stop using all
types of asbestos. Nevertheless, current use
varies widely. Some countries have imposed
strict regulations to limit exposure, others have
adopted bans, and yet others have intervened
less and have continued to use varying quanti-
ties of asbestos. The global burden of asbestos
diseases over time will be uneven, reﬂecting the
extent and patterns of asbestos use.
Globally, each year, an estimated 125 mil-
lion people are occupationally exposed to
asbestos, and 90,000 die from asbestos diseases
(WHO 2006a). Around the time of peak use
in the mid-1970s, approximately 25 countries
produced asbestos and 85 countries manufac-
tured asbestos products (Virta 2005). In 1983,
Iceland became the first country to ban
asbestos, reﬂecting increasing recognition, pre-
dominantly in Western countries, of health
risks associated with asbestos exposure.
Subsequently, 40 or more countries have
adopted bans (WHO 2006a).
Among the asbestos diseases, mesothe-
lioma is the most sensitive and speciﬁc indica-
tor of the disease burden in the population
(Weill et al. 2004). The annual incidence of
mesothelioma has been estimated at 10,000
cases in Western Europe, North America,
Japan, and Australia combined (Anonymous
1997). Peto et al. (1995, 1999) predicted a
dramatic increase in future mesothelioma
deaths in the United Kingdom and Europe.
Several statistical projections have been made
since then, suggesting that deaths from
mesothelioma will increase in many countries.
We recently reported that per capita
asbestos use is a useful surrogate for the gen-
eral asbestos exposure level of a population
and may be used for estimation of health
effects (Lin et al. 2007). Information is lim-
ited at the global level concerning the rela-
tionship between mesothelioma trends and
trends in asbestos use, and the status of bans.
Our aim in the present study was to assess, on
a global scale, national experiences of recent
mortality from mesothelioma, historical
trends in asbestos use, adoption of bans, and
their possible interrelationships. We focused
specifically on pleural mesothelioma in men
because a high proportion of such cases arise
from asbestos exposure.
Materials and Methods
Indicators of mortality. The primary source of
information on mortality was the WHO
database (WHO 2006b). It registers the num-
ber of deaths by country according to the
International Classiﬁcation of Diseases (ICD).
Several countries shifted from coding based on
the ICD 9th Revision (ICD-9) to that based on
the 10th Revision (ICD-10) (WHO 1992) dur-
ing our 1996–2005 study period [year of
change ranged from 1996 to 2002, with a
median of 1998 in the countries studied;
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BACKGROUND: In response to the health risks posed by asbestos exposure, some countries have
imposed strict regulations and adopted bans, whereas other countries have intervened less and con-
tinue to use varying quantities of asbestos.
OBJECTIVES: This study was designed to assess, on a global scale, national experiences of recent
mortality from pleural mesothelioma, historical trends in asbestos use, adoption of bans, and their
possible interrelationships.
METHODS: For 31 countries with available data, we analyzed recent pleural mesothelioma
(International Classification of Diseases, 10th Revision) mortality rates (MRs) using age-adjusted
period MRs (deaths/million/year) from 1996 to 2005. We calculated annual percent changes
(APCs) in age-adjusted MRs to characterize trends during the period. We characterized historical
patterns of asbestos use by per capita asbestos use (kilograms per capita/year) and the status of
national bans.
RESULTS: Period MRs increased with statistical signiﬁcance in ﬁve countries, with marginal signiﬁ-
cance in two countries, and were equivocal in 24 countries (ﬁve countries in Northern and Western
Europe recorded negative APC values). Countries adopting asbestos bans reduced use rates about
twice as fast as those not adopting bans. Turning points in use preceded bans. Change in asbestos
use during 1970–1985 was a signiﬁcant predictor of APC in mortality for pleural mesothelioma,
with an adjusted R2 value of 0.47 (p < 0.0001).
CONCLUSIONS: The observed disparities in global mesothelioma trends likely relate to country-to-
country disparities in asbestos use trends.
KEY WORDS: asbestos, asbestos-related diseases, ban, epidemiology, lung cancer, mesothelioma,
mortality, occupational cancer, pleural mesothelioma. Environ Health Perspect 116:1675–1680
(2008). doi:10.1289/ehp.11272 available via http://dx.doi.org/ [Online 14 August 2008]suppl.pdf)]. Notably, the disease category of
mesothelioma was initially introduced into
ICD-10 codes comprising subcategories of
pleural (C45.0), peritoneal (C45.1), pericardial
(C45.2), other sites (C45.7), and unspeciﬁed
(C45.9). In our study, we defined pleural
mesothelioma as a composite of mesothelioma
of the pleura (C45.0) and unspeciﬁed mesothe-
lioma (C45.9) because in certain countries,
including the United States, most mesothe-
lioma was coded as C45.9 instead of C45.0.
From the database, we obtained the annual
numbers of male deaths for each country, based
on 5-year age intervals.
We obtained national population data
from the WHO (2006b), the U.S. Census
Bureau (2006), the United Nations (2006),
and Lahmeyer (2007), prioritized for use in
that order. For each country, we calculated
age-adjusted annual mortality rates (annual
MRs; deaths/million/year) by dividing the
number of male deaths in each year by the size
of the corresponding male national population,
which we age-standardized to the world
standard population of the year 2000 (Ahmad
et al. 2000). We similarly calculated period
MRs by dividing the average annual number
of male deaths from 1996 to 2005 by the
average sizes of male national populations,
also age-standardized.
To characterize the trend of mortality, we
estimated the annual percent change (APC)
of annual MRs using the Joinpoint software
(version 3.0, U.S. National Cancer Institute,
Bethesda, MD, USA). Brieﬂy, the method ﬁts
a least-squares regression line to the natural
logarithm of the rates using calendar year as a
regressor variable. That is, y = bx + c, where y
is the ln(rate), x is the calendar year, and c is
the intercept. Hence, APC = 100 × (eb – 1)
(Jemal et al. 2000; Lasithiotakis et al. 2006;
Ries et al. 1997). In addition, we calculated
p-values for APC = 0 and 95% confidence
intervals (CIs) of APCs. Testing the hypothe-
sis that APC = 0 is equivalent to testing the
hypothesis that the regression slope parameter
is equal to zero (Ries et al. 1997). We
assumed a linear change of trends in log rates
over time. Because trends pertained to a
10-year period, we limited analyses to coun-
tries with at least 4 years of pleural mesothe-
lioma data under ICD-10 codes (the range
was 4–9 years, with a median of 6 years).
Indicators of asbestos use. We extracted data
on new use of asbestos by country from a U.S.
Geological Survey (USGS) report (Virta 2006).
We defined “use” as production plus import
minus export (Virta 2006). We considered neg-
ative values of use (caused by storage and the
like) uninformative and excluded them from
further analyses. To characterize trends, we
divided use numbers by sizes of national popu-
lations for the corresponding year or period (to
give use per capita, expressed as kilograms per
capita/year) (Lin et al. 2007). The USGS data-
base provides data only sparsely in 10-year
intervals up to 1960, 5-year intervals from
1970–1995, and annually for 1996–2003. We
classiﬁed use of ≥ 3.0 kg per capita/year as high
and ≥ 4.0 as very high, and change in use dur-
ing a particular period (Δ, kilograms per
capita/year) as the difference between average
use during the earlier and latter subperiods
(halves) of the entire period (e.g., for the period
1960–1985, change is the difference between
the average use of 1960 and 1970 and the aver-
age use of 1975, 1980, and 1985; for the period
1970–1985, change is the difference between
the average use of 1970 and 1975 and the aver-
age use of 1980 and 1985). We calculated Δ
values for all possible combinations of available
data. We retrieved national ban status from the
database compiled by Kazan-Allen (2005,
2006) and verified it by separate reports. To
describe historical trends in asbestos use and
relationships with banning status, we grouped
countries according to their national ban status
into early-ban (adopted by 1995), late-ban
(1996–2006), and no-ban groups.
Statistical analysis. We adapted geographic
grouping of countries from the U.N. Statistics
Division (United Nations 2006). We per-
formed statistical analyses using Joinpoint,
SPSS version 12.0 (SPSS Inc., Chicago, IL,
USA), and Excel 2003 (Microsoft Corp.,
Redmond, WA, USA). When we used
Joinpoint, we assumed a linear change (or 0
joinpoint) during the observed period, with a
maximum length of 10 years. We deemed p <
0.05 statistically signiﬁcant and 0.05 < p < 0.10
marginally significant. We use the terms
“increase” (denoted as ↑) or “decrease” (↓)
when APC was marginally or statistically sig-
niﬁcant, and “equivocal” (↔) when APC and
its significance level were neither statistically
nor marginally signiﬁcant.
When we evaluated trends in asbestos use
by groups of countries, we weighted means by
the size of national populations of the cor-
responding periods. We analyzed data from
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Table 1. Recent trend in mortality from pleural mesotheliomaa in men.
Period MRb (no.c) APCd Male populationf
Country (code) (deaths/million/year) [%/year (95% CI)] Trende (million)
Asia
Israel (ISR) 5.5 (5) 6.6 (–14.9 to 33.4) ↔ 3.1 
Japan (JPN) 4.8 (9) 3.9 (2.6 to 5.2) ↑** 61.4 
Eastern Europe and Southern Europe
Croatia (HRV) 8.8 (9) 11.0 (2.7 to 20.0) ↑** 2.2 
Czech Republic (CZE) 3.2 (9) 6.3 (–1.7 to 15.0) ↔ 5.0 
Hungary (HUN) 2.5 (8) 11.0 (3.3 to 19.3) ↑** 4.9 
Poland (POL) 2.0 (6) 5.2 (–5.2 to 16.7) ↔ 18.7 
Romania (ROU) 1.9 (6) 1.2 (–11.2 to 15.3) ↔ 10.9 
Spain (ESP) 5.7 (6) 0.7 (–6.6 to 8.7) ↔ 19.8 
Northern Europe and Western Europe
Austria (AUT) 7.8 (4) –5.9 (–20.9 to 12.0) ↔ 3.9 
Denmark (DNK) 12.9 (6) 4.6 (–6.5 to 16.9) ↔ 2.6 
Finland (FIN) 12.6 (9) –0.3 (–3.9 to 3.6) ↔ 2.5 
France (FRA) 12.7 (4) –1.0 (–14.7 to 14.9) ↔ 28.7 
Germany (DEU) 12.0 (7) 3.3 (–0.8 to 7.6) ↑* 40.1 
Iceland (ISL) 10.1 (7) –1.4 (–28.8 to 36.5) ↔ 0.1 
Lithuania (LTU) 2.0 (5) 12.3 (–34.3 to 92.1) ↔ 1.6 
Luxembourg (LUX) 12.7 (7) 5.4 (–11.0 to 24.8) ↔ 0.2 
Netherlands (NLD) 30.0 (9) 0.0 (–1.5 to 1.6) ↔ 7.9 
Norway (NOR) 12.7 (9) –2.7 (–7.5 to 2.3) ↔ 2.2 
Sweden (SWE) 12.8 (6) 3.5 (–2.0 to 9.2) ↔ 4.4 
United Kingdom (GBR) 31.1 (4) 0.5 (–4.0 to 5.3) ↔ 29.1 
Americas excluding South America
Canada (CAN) 10.3 (4) 5.6 (–7.4 to 20.4) ↔ 15.1 
Cuba (CUB) 0.6 (4) 5.2 (–36.1 to 73.2) ↔ 5.6 
Mexico (MEX) 2.2 (6) 2.9 (–7.2 to 14.2) ↔ 49.4 
United States of America (USA) 9.0 (4) 0.8 (–2.4 to 4.1) ↔ 135.1 
South America
Argentina (ARG) 2.5 (7) 8.9 (3.3 to 14.7) ↑** 18.6 
Brazil (BRA) 0.5 (6) 9.0 (0.1 to 18.7) ↑** 87.3 
Chile (CHL) 3.1 (7) 3.3 (–8.1 to 16.2) ↔ 7.5 
Ecuador (ECU) 0.5 (4) 16.4 (–37.5 to 116.7) ↔ 6.3 
Uruguay (URY) 2.3 (5) 13.6 (–43.7 to 129.2) ↔ 1.6 
Oceania
Australia (AUS) 25.5 (6) 4.6 (–0.6 to 10.1) ↑* 9.5 
New Zealand (NZL) 20.5 (4) 10.4 (–10.3 to 35.7) ↔ 1.9 
aSee “Materials and Methods” for our definition of mesothelioma. bPeriod MR from 1996 to 2005, age-adjusted to the
world population of 2000. cNumber of years with available data. dAPC, together with its 95% CI and p-values, were calcu-
lated with Joinpoint software. eTrend: ↑ when APC > 0 (p < 0.10); ↓ when APC < 0 (p < 0.10); ↔ when p > 0.10 for APC.
fAverage of male national population from 1996 to 2005. *Marginally signiﬁcant (0.05 < p < 0.10). **Statistically signiﬁcant
(p < 0.05).the United States separately because of the
known high degree of historical asbestos use.
We regressed recent changes in pleural
mesothelioma mortality (APC values) against
historical changes in use of asbestos (Δ values
for various periods). We weighted each regres-
sion model by the sizes of male national
populations in the corresponding period.
Results
Trends in mortality. Table 1 shows the period
MRs and APCs in mortality for pleural
mesothelioma and male population by coun-
try. Mortality from pleural mesothelioma was
highest in United Kingdom (31.1 deaths/
million/year), with a global median of
7.8 deaths/million/year. Trends of mortality
were as follows: statistically significant
increases in ﬁve countries, marginally signiﬁ-
cant increases in two countries, and equivocal
results in 24 countries. Global median APC
was 4.5%/year, and negative values of APC
were recorded in five countries of Northern
and Western Europe. We observed increasing
trends more often in countries with above-
median period MR values than in those with
below-median values (26.7%, or 4 of 15, vs.
20.0%, or 3 of 15).
Regionally, countries of Northern and
Western Europe and Oceania showed high
and stable MRs; those of Eastern and
Southern Europe, South America, and Asia
showed low and increasing rates.
Trends in asbestos use. Asbestos use peaks
were higher and occurred earlier in the coun-
tries of Northern and Western Europe,
Oceania, and the Americas (excluding South
America) (Table 2). Very high (≥ 4.0 kg per
capita/year) asbestos use was recorded in
Australia, Canada, and several countries of
Northern and Western Europe. 
Asbestos use fell most quickly in countries
that adopted early bans, at an intermediate rate
in countries with late ban adoption, and most
slowly in countries without bans (Figure 1).
Specifically, the early-ban group, during its
period of adopting bans, recorded a reduction
rate of –8.3%/year, from 2.4 kg per capita/year
in 1983 (ﬁrst ban) to < 0.01 kg per capita/year
in 1995 (last ban). This was about twice as fast
as the late-ban and no-ban groups, which
recorded a reduction rate of –4.1%/year and
–5.2%/year, respectively, during the same
period. Similarly, the late-ban group, during its
period of adopting bans, recorded a reduction
rate of –10.7%/year, from 0.7 kg per
capita/year in 1996 (first ban) to 0.2 kg per
capita/year in 2003. During the same period,
the value for the no-ban group was
–4.9%/year, resulting in a 2.2-fold quicker
reduction rate in the late-ban group. The his-
torical use pattern of the United States differed
from that of other countries. The United
States recorded the earliest and maximal peak
use at 4.2 kg per capita/year in 1950, followed
by progressive reduction over four decades and
approaching 0.02 kg per capita/year in 2003,
equating to a reduction rate of –1.9%/year.
The no-ban group had the lowest peak but
currently maintains the highest level of asbestos
use at 0.4 kg per capita/year. The period of
1970–1985 contained historical use peaks with
a notable shift to downward trends for many
but not all countries.
Interrelationships. The change in asbestos
use (Δ) during 1970–1985 was the strongest
predictor of APC among the many periods
tried, with an adjusted R2 value of 0.47 (p <
0.0001) (Table 3). Changes in asbestos use
during other adjacent periods (e.g., 1960–1990,
1970–1990) also predicted APC in mortality,
each with relatively high statistical signifi-
cance. Figure 2 shows the positive log-linear
relationships between changes in asbestos use
and APCs in mortality, where increments in
recent MRs are associated with increments in
historical asbestos use.
Discussion
The present study identiﬁed wide differences
in recent mortality from pleural mesothe-
lioma in various countries. Recent MRs were
highest in the countries of Northern and
Western Europe and Oceania. Increasing
Mortality from mesothelioma, asbestos use, and bans
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Table 2. Historical trend in per capita asbestos use and status of national ban.
Change in
Use of asbestosa (kg per capita/year) use (Δ) from  National
Country code 1950s 1960s 1970s 1980s 1990s 2000s 1970 to 1985b banc
Asia
ISR 3.13 2.87  1.23 0.78  0.44  0.02  –0.59  No  ban
JPN 0.56 2.02  2.92 2.66  1.81  0.46  0.12  2004
Othersd (n = 39) 0.06  0.15  0.25  0.27  0.30  0.31  0.05  3/39
Eastern Europe and Southern Europe 
HRV 0.39 1.13  2.56 2.36  0.95  0.65  0.49  No  ban
CZE 1.62 2.36  2.91 2.73  1.30  0.14  0.21  2005
HUN 0.76 1.23  2.87 3.29  1.50  0.16  1.32  2005
POL 0.36 1.24  2.36 2.09  1.05  0.01  –0.11  1997
ROU NA1 NA1 1.08 0.19 0.52  0.55  –1.73  2007
ESP 0.32 1.37  2.23 1.26  0.80  0.18  –1.07  2002
Othersd (n = 15) 0.79  1.57  2.35  2.05  2.35  1.72  0.30  5/15
Northern Europe and Western Europe
AUT 1.16 3.19  3.92 2.08  0.36  0.00  –1.77  1990
DNK 3.07 4.80  4.42 1.62  0.09  NA2 –2.96  1986
FIN 2.16 2.26  1.89 0.78  NA1 0  –1.53  1992
FRA 1.38 2.41  2.64 1.53  0.73  0.00  –1.06  1996
DEU 1.84 2.60  4.44 2.43  0.10  0.00  –0.30  1993
ISL 0.21 2.62  1.70 0.02  0 0.00  –2.52  1983
LTU NA1 NA1 NA1 NA1 0.54 0.06  NA1 2005
LUX 4.02 5.54  5.30 3.23  1.61  0.00  –2.04  2002
NLD 1.29 1.70  1.82 0.72  0.21  0.00  –1.20  1994
NOR 1.38 2.00  1.16 0.03  0 0.00  –1.72  1984
SWE 1.85 2.30  1.44 0.11  0.04  NA2 –1.96  1986
GBR 2.62 2.90  2.27 0.87  0.18  0.00  –1.41  1999
Othersd (n = 5) 3.05  4.32  4.05  2.40  0.93  0.05  –1.30  5/5
Americas excluding South America
CAN 2.76 3.46  4.37 2.74  1.96  0.32  –1.66  No  ban
CUB NA1 NA1 NA1 0.15 0.36 0.74  NA1 No  ban
MEX 0.28 0.57  0.97 0.77  0.39  0.26  0.04  No  ban
USA 3.82 3.32  2.40 0.77  0.08  0.01  –1.73  No  ban
Othersd (n = 12) 0.06  0.22  0.44  0.29  0.07  0.07  –0.08  0/12
South America
ARG NA1 0.88 0.76 0.40 0.18 0.04  –0.26  2001
BRA 0.27 0.38  0.99 1.25  1.07  0.74  0.66  2001
CHL 0.07 0.92  0.56 0.64  0.55  0.03  0.14  2001
ECU NA1 NA1 0.67 0.52 0.14  0.26  0.29  No  ban
URY NA1 0.74 0.75 0.54 0.47 0.08  –0.20  2002
Othersd (n = 6) 0.27  0.43  0.60  0.47  0.29  0.19  –0.04  0/6
Oceania
AUS 3.24 4.84  5.11 1.82  0.09  0.03  –2.71  2003
NZL 2.05 2.56  2.90 1.00  NA1 NA1 –2.56  No  ban
Othersd (n = 3) NA1 NA1 NA1 NA1 NA1 0.22  NA1 0/3
Abbreviations: NA 1, data not available; NA 2, not applicable because of negative use data: 0.00 when the calculated data
were < 0.005; 0 if there are no data after the year the ban was introduced. See Table 1 for country codes.
aNumbers corresponding to use of asbestos by country and region were calculated as annual use per capita averaged
over the respective decade. bChange in use (Δ, kilograms per capita/year) during the period defined as the difference
between the average of consumption during the former subperiod (1970–1975) and latter subperiod (1980–1985). cYear
first achieved or year planned to achieve ban. When shown as fraction, the numerator is the number of countries that
achieved bans and the denominator is the number of other countries in the region. dData on asbestos use were available
(but mortality data unavailable) for others in each region, in which case data were aggregated.trends, as measured by APCs in mortality,
were common in the countries of Eastern and
Southern Europe, Asia, and South America.
We assessed mortality trends over the most
recent 10-year window, using the earliest
opportunity to analyze the disease under the
standard code of ICD-10. However, the study
period was inadequate to depict trends in
many countries. National data recorded only
under ICD-9 had to be precluded (e.g., Italy).
For the countries shifting from ICD-9 to
ICD-10 during the study period, we limited
our analyses to the period when data were
recorded under ICD-10.
Further, data may lack comparability,
especially because mesothelioma is rare and
difﬁcult to diagnose. A major concern is that
increasing trends recorded in countries with
low mortality levels could be explained by
improved disease recognition (Peto et al.
1995; Weill et al. 2004), and such secular
trends in diagnosis would be statistically indis-
tinguishable from real increases (Peto et al.
1995). Our study revealed increasing mortal-
ity trends in the group that recorded above-
median values for the period MR (group 1)
than the group that recorded below-median
values for the period MR (group 2). Such bias
is likely to be less serious in group 1 than
group 2. Thus, although increases in disease
recognition are probable, this factor alone does
not explain the increasing trends. The propor-
tionality with which recent mortality trends
were related to historical trends of asbestos use
offers a more compelling explanation.
Pleural mesothelioma is the predominant
type of mesothelioma and is strongly related to
asbestos exposure. However, in certain coun-
tries, most mesothelioma was coded into the
subcategory of unspecified mesothelioma
(C45.9) instead of the subcategory of pleural
mesothelioma (C45.0): the ratio of C45.0 to
C45.0 + C45.9 ranged from 0.08 (Israel),
0.11 (United States), and 0.12 (Canada) to
0.94 (New Zealand) and 0.98 (Finland), with
a median of 0.63. We therefore created a com-
posite category of C45.0 and C45.9 to ensure
comparability, which we deemed more reason-
able than the alternative choices of analyzing
only C45.0 or mixing C45.0 with other sub-
categories—for example, peritoneal (C45.1) or
pericardial (C45.2) or other sites (C45.7).
Our ﬁndings on mortality trends are com-
parable with trends reported earlier for indi-
vidual countries, including the Netherlands
(Segura et al. 2003), Sweden (Burdorf et al.
2005), Finland (Karjalainen et al. 1997), and
Denmark (Kjaergaard and Andersson 2000),
as well as overall Europe (Montanaro et al.
2003). However, methods and indices
employed to evaluate trends are unique to
each study, and comparisons cannot exceed
the general trend characteristics. For the
United States, we recorded equivocal trends
(i.e., APC = 0.8%). Similarly, Price (1997)
ﬁrst observed that the annual growth rate dur-
ing 1973–1992 was declining, and Price and
Ware (2004) reported “no substantive
changes in time pattern of mesothelioma inci-
dence since 1992.” Furthermore, surveillance
information in United States does not show
an apparent trend from 1999 to 2002
(National Institute for Occupational Safety
and Health 2005).
Regarding historical trends in asbestos
use, we identiﬁed several distinctive patterns:
Nishikawa et al.
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Table 3. Relation between recent change in pleural mesothelioma mortality and historical change in use of
asbestos based on regression analyses.a
Period for use of asbestos No. of countries Adjusted R2 p-Value
1950
1960 23 –0.035 0.615 
1970 24 –0.038 0.689 
1975 25 0.000 0.325 
1980 25 0.073 0.102 
1985 25 0.182 0.019 
1990 27 0.277 0.003 
1960
1970 24 –0.044 0.857 
1975 23 0.052 0.151 
1980 27 0.201 0.011 
1985 27 0.300 0.002 
1990 29 0.415 <  0.001
1970
1975 26 0.121 0.046 
1980 26 0.348 0.001 
1985 29 0.466 <  0.001
1990 29 0.366 <  0.001
1975
1980 27 0.328 0.001 
1985 28 0.267 0.003 
1990 29 0.091 0.062 
1980
1985 28 –0.031 0.675 
1990 26 –0.006 0.368 
1985
1990 27 0.037 0.170 
aAPC of the age-adjusted annual MRs from 1996 to 2005 (dependent variable) versus change in use during the cor-
responding period (independent variable).
Figure 1. Historical trends in use of asbestos from 1950 to 2003 grouped by status of national bans. Early-
ban countries are countries that adopted bans in 1995 or before (n = 8); late-ban countries adopted bans
from 1996 to 2006 (n = 14); no-ban countries, excluding the United States, did not adopt bans until 2007 (n =
8). Asbestos use (y-axis) is per capita yearly use (averages weighted by the sizes of national populations).
The USGS (Virta 2006) database provides data only sparsely in 10-year intervals up to 1960, 5-year inter-
vals from 1970–1995, and annually for 1996–2003. Straight lines connect available data.
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×a) a very early (1950) and very high (≥ 4.0 kg
per capita/year) peak followed by a progres-
sive decline (in the United States); b) a mid-
term (1960s-1980s) very high peak, followed
by an abrupt decline (Australia and several
Northern and Western European countries);
and c) a late (≥ 1980) and relatively moderate
peak followed by a moderate decline (Hungary
and Japan).
In the United States, a “bubble” in
asbestos use occurred in the mid-20th century
because of early manufacturing research,
industrial demand, and ready supply from
Canada (Virta 2006). However, the United
States was also the ﬁrst to experience the burst
of the bubble due to growing health concerns
and liability issues (Virta 2006). In 1989, the
U.S. Environmental Protection Agency (EPA)
banned most asbestos-containing products,
but this regulation was overturned by the
U.S. Court of Appeals in 1991 (U.S. EPA
1989). Nevertheless, use fell to 4,600 tons in
2003 (0.7% of peak use). In many other
countries, increasing use of asbestos paralleled
the growth curves of industrialization.
Generally, countries recording early and
high levels of asbestos use displayed peaks by
1980 followed by downward trends. The
turning points preceded the earliest bans and
are thus not direct outcomes of bans. Rather,
paths leading to bans likely entailed regulatory
restrictions and economic incentives and dis-
incentives, which furthered reduction of use.
Virta (2005, 2006) attributed maturation of
the asbestos market superimposed on health
issues as the main reason for the decline in use
since 1980. Several relevant events with inter-
national impact coincided with this period.
The International Agency for Research on
Cancer (IARC), after acknowledging the car-
cinogenicity of asbestos in 1973 (IARC
1973), classiﬁed asbestos as a human carcino-
gen in 1977 (IARC 1977). The ILO added
lung cancer and mesothelioma caused by
asbestos to its list of occupational diseases in
1980 (ILO 1980) and adopted the Asbestos
Convention in 1986 (ILO 1986). It was also
around this period that the landmark studies
by Selikoff and colleagues (Nicholson et al.
1982; Selikoff et al. 1984a, 1984b) gained
wide recognition.
The adoption of bans by Northern
European countries in the 1980s set a prece-
dent for other countries, but the particular
restrictions imposed by a “ban” vary by coun-
try, and the rates at which the absolute zero
use levels were reached also vary. Collectively,
countries adopting bans reduced use about
twice as fast as those with lesser interventions.
Notably, the countries of Eastern and
Southern Europe (grouped here as “other”
countries in Table 2) have continued to use
asbestos, approaching high levels even after
the turn of the century. The recent per capita
use for the “other” Asian countries is low but
shows little sign of decreasing. This is largely
attributable to sustained use in China and
India. Hence, our findings reinforce the
widely held concern that the center of
asbestos use is shifting to industrializing
countries (Kazan-Allen 2005; LaDou 2004;
Takahashi and Karjalainen 2003). Moreover,
if the ecologic relationship reported here
holds true for the future, corresponding risks
should be anticipated in these countries.
Regression analyses showed the strongest
relationship between recent APC in mortality
from pleural mesothelioma and change in
asbestos use during 1970–1985 (adjusted R2
= 0.47, p < 0.0001). The same analyses incor-
porating countries with six or more data
points produced similar results (data not
shown). The strong relationship is largely
attributable to countries recording recent
mortality trends in the same direction as his-
torical use trends (lower-left and upper-right
quadrants in Figure 2). The positive correla-
tions found for change indicators of a number
of periods in the present study reinforce the
notion that per capita asbestos use is related
to subsequent mortality level at the national
level, as we reported earlier using absolute-
level indicators (Lin et al. 2007). However,
the time difference (i.e., latency) for the best
predictive model was only 22.5 years (from
mid-1977 to 2000), and thus the observed
relationship may have reflected only early
effects. In this connection, recent mortality
trends of the eight early-ban countries are
noteworthy: Seven countries recorded had
equivocal MR trends, and only Germany had
an increase in MR trend (Table 1). Germany
actually recorded a historical use peak in
1980, trailing other early-ban countries by
5–10 years (detailed data not shown) and pre-
sumably delaying favorable changes in mor-
tality trend. Continuing use of asbestos results
in the accumulation of asbestos in the envi-
ronment, thus creating possibilities for ongo-
ing exposure due to maintenance, repair, and
demolition during the entire life span of
asbestos products. Given the long latency
time, the mortality data available did not
allow us to analyze the full consequences of
such effects after the new use in longer term.
Nevertheless, we observed significant (albeit
weaker) relationships for changes in use dur-
ing other close periods with longer latencies
[e.g., 1950–1985 (latency 32.5 years) and
1950–1990 (30 years)].
In this study, we took advantage of the
earliest opportunity to analyze mortality
trends in a range of countries. Limitations
included our dependence on a crude indicator
of exposure (i.e., asbestos use per capita for
sparse years with limited data), “bans” entail-
ing varying restrictions on use that could not
be measured, and no distinctions available
Mortality from mesothelioma, asbestos use, and bans
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Figure 2. Trend of MRs for male pleural mesothelioma in relation to change in asbestos use. See Table 1
for country codes. Circles have areas proportional to the sizes of male national populations; the smaller
equal sizes indicate male national populations < 5,000,000. We deﬁned the trend of MRs (y-axis) as APC, as
calculated by the Joinpoint software. Bivariate relationships were examined by linear regression,
weighted by the sizes of male national populations, and produced the following model: y = 0.011x + 2.022
(adjusted R2 = 0.47, p < 0.0001).
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Change in asbestos use (Δ) during 1970–1985 (kg per capita/year)between asbestos fiber types. Mortality data
were limited to 31 countries, with developing
countries likely lacking well-developed sur-
veillance systems to assure quality of data.
Moreover, the observed relationships are eco-
logic at the national level only, so all ﬁndings
should be cautiously interpreted.
Because there is no safe threshold of expo-
sure to asbestos, any degree of contact will
involve some risk. On the other hand, the
degree of risk is related to exposure. The
experience of many countries suggests that
attempts to reduce exposure without a con-
current reduction in overall use are insuffi-
cient to control risk. Countries implementing
bans recorded reductions in asbestos use
about twice as fast as those not adopting bans,
for which our study period was probably too
early to observe their full effects. However,
the observed disparities in global mesothe-
lioma trends are likely to relate to country-to-
country disparities in asbestos use trends.
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